This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background and Objectives Reliable seizure forecasting has important implications in epilepsy treatment and improving the quality of lives for people with epilepsy. High-frequency activity (HFA) is a biomarker that has received significant attention over the past 2 decades, but its predictive value in seizure forecasting remains uncertain. This work aimed to determine the utility of HFA in seizure forecasting.
Methods We used seizure data and HFA (80–170 Hz) data obtained from long-term, continuous intracranial EEG recordings of patients with drug-resistant epilepsy. Instantaneous rates and phases of HFA cycles were used as features for seizure forecasting. Seizure forecasts based on each individual HFA feature, and with the use of a combined approach, were generated pseudo-prospectively (causally). To compute the instantaneous phases for pseudo-prospective forecasting, real-time phase estimation based on an autoregressive model was used. Features were combined with a weighted average approach. The performance of seizure forecasting was primarily evaluated by the area under the curve (AUC).
Results Of 15 studied patients (median recording duration 557 days, median seizures 151), 12 patients with >10 seizures after 100 recording days were included in the pseudo-prospective analysis. The presented real-time phase estimation is feasible and can causally estimate the instantaneous phases of HFA cycles with high accuracy. Pseudo-prospective seizure forecasting based on HFA rates and phases performed significantly better than chance in 11 of 12 patients, although there were patient-specific differences. Combining rate and phase information improved forecasting performance compared to using either feature alone. The combined forecast using the best-performing channel yielded a median AUC of 0.70, a median sensitivity of 0.57, and a median specificity of 0.77.
Discussion These findings show that HFA could be useful for seizure forecasting and represent proof of concept for using prior information of patient-specific relationships between HFA and seizures in pseudo-prospective forecasting. Future seizure forecasting algorithms might benefit from the inclusion of HFA, and the real-time phase estimation approach can be extended to other biomarkers.
Classification of Evidence This study provides Class IV evidence that HFA (80–170 Hz) in long-term continuous intracranial EEG can be useful to forecast seizures in patients with refractory epilepsy.
Glossary
- AUC=
- area under the curve;
- GSS=
- geometric mean of sensitivity and specificity;
- HFA=
- high-frequency activity;
- iEEG=
- intracranial EEG;
- ROC=
- receiver operating characteristic
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Submitted and externally peer reviewed. The handling editor was Barbara Jobst, MD, PhD, FAAN.
Class of Evidence: NPub.org/coe
- Received August 17, 2021.
- Accepted in final form February 21, 2022.
- © 2022 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
